Statistical Metamodeling for revealing synergistic antimicrobial interactions

PLoS ONE

Volumn 5, Issue 11, 2010, Pages

  Chen, Chia Hsiang ^a   Gau, Vincent ^b   Zhang, Donna D ^c   Liao, Joseph C ^d   Wang, Fei Yue ^e   Wong, Pak Kin ^a,c  

^a University of Arizona   (United States)

^b GeneFluidics Inc   (United States)

^c UNIVERSITY OF ARIZONA   (United States)

^d STANFORD UNIVERSITY   (United States)

^e INSTITUTE OF AUTOMATION   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTIINFECTIVE AGENT; CINNAMON OIL; GENTAMICIN; PEPPERMINT OIL; SULFAMETHOXAZOLE; TRIMETHOPRIM; UNCLASSIFIED DRUG; VEGETABLE OIL;

ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; CONTROLLED STUDY; DRUG POTENTIATION; DRUG SCREENING; GROWTH INHIBITION; METAMODEL ANTIMICROBIAL COCKTAIL OPTIMIZATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; STATISTICAL MODEL; ALGORITHM; BACTERIAL INFECTION; BACTERIUM; DRUG EFFECT; GROWTH, DEVELOPMENT AND AGING; HUMAN; METHODOLOGY; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY;

BACTERIA (MICROORGANISMS);

ALGORITHMS; ANTI-INFECTIVE AGENTS; BACTERIA; BACTERIAL INFECTIONS; DRUG EVALUATION, PRECLINICAL; DRUG SYNERGISM; GENTAMICINS; HUMANS; MICROBIAL SENSITIVITY TESTS; TRIMETHOPRIM;

EID: 78649760578     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0015472     Document Type: Article

References (36)

1. Pinner RW, Teutsch SM, Simonsen L, Klug LA, Graber JM, et al. (1996) Trends in infectious diseases mortality in the United States. Jama-Journal of the American Medical Association 275: 189-193.
2. Levy SB, Marshall B (2004) Antibacterial resistance worldwide: causes, challenges and responses. Nat Med 10: S122-129.
3. Livermore DM, Woodford N (2006) The beta-lactamase threat in Enterobac-teriaceae, Pseudomonas and Acinetobacter. Trends in Microbiology 14: 413-420.
4. Kollef MH, Fraser VJ (2001) Antibiotic resistance in the intensive care unit. Annals of Internal Medicine 134: 298-314.
5. Walsh C (2003) Antibiotics: actions, origins, resistance. Washington, D.C.: ASM Press. x, 335 p.
6. Projan SJ (2003) Why is big Pharma getting out of antibacterial drug discovery? Curr Opin Microbiol 6: 427-430.
7. Walsh C (2003) Where will new antibiotics come from? Nature Reviews Microbiology 1: 65-70.
8. Friedman M, Buick R, Elliott CT (2004) Antibacterial activities of naturally occurring compounds against antibiotic-resistant Bacillus cereus vegetative cells and spores, Escherichia coli, and Staphylococcus aureus. Journal of Food Protection 67: 1774-1778.
9. Chang ST, Chen PF, Chang SC (2001) Antibacterial activity of leaf essential oils and their constituents from Cinnamomum osmophloeum. Journal of Ethno-pharmacology 77: 123-127.
10. Inouye S, Takizawa T, Yamaguchi H (2001) Antibacterial activity of essential oils and their major constituents against respiratory tract pathogens by gaseous contact. Journal of Antimicrobial Chemotherapy 47: 565-573.
11. Forrest RD (1982) Early History of Wound Treatment. Journal of the Royal Society of Medicine 75: 198-205.
12. Kolusheva S, Boyer L, Jelinek R (2000) A colorimetric assay for rapid screening of antimicrobial peptides. Nat Biotechnol 18: 225-227.
13. Clardy J, Fischbach MA, Walsh CT (2006) New antibiotics from bacterial natural products. Nat Biotechnol 24: 1541-1550.
14. Schreiber SL (2000) Target-oriented and diversity-oriented organic synthesis in drug discovery. Science 287: 1964-1969.
15. Perelson AS, Essunger P, Cao YZ, Vesanen M, Hurley A, et al. (1997) Decay characteristics of HIV-1-infected compartments during combination therapy. Nature 387: 188-191.
16. Pui CH, Evans WE (2006) Drug therapy - Treatment of acute lymphoblastic leukemia. New England Journal of Medicine 354: 166-178.
17. Sundin DP, Sandoval R, Molitoris BA (2001) Gentamicin inhibits renal protein and phospholipid metabolism in rats: Implications involving intracellular trafficking. Journal of the American Society of Nephrology 12: 114-123.
18. Hewitt WL (1974) Gentamicin: toxicity in perspective. Postgrad Med J 50 Suppl 7: 55-61.
19. Bushby SRM, Hitching GH. (1968) Trimethoprim a Sulphonamide Potentiator. British Journal of Pharmacology 33: 72.
20. Feala JD, Cortes J, Duxbury PM, Piermarocchi C, D. MA, et al. (2010) Systems approaches and algorithms for discovery of combinatorial therapies. Wiley Interdisciplinary Reviews: Systems Biology and Medicine 2: 181-193.
21. Antony J (2003) Design of experiments for engineers and scientists. Oxford; Burlinton MA: Butterworth-Heinemann. x, 152 p.
22. Bonabeau E, Dorigo M, Theraulaz G (2000) Inspiration for optimization from social insect behaviour. Nature 406: 39-42.
23. Hartmann AK, Rieger H (2002) Optimization algorithms in physics. Berlin: Wiley-VCH. x, 372 p.
24. Forrest S (1993) Genetic Algorithms - Principles of Natural-Selection Applied to Computation. Science 261: 872-878.
25. Kirkpatrick S, Gelatt CD, Vecchi MP (1983) Optimization by Simulated Annealing. Science 220: 671-680.
26. Wong PK, Yu FQ, Shahangian A, Cheng GH, Sun R, et al. (2008) Closed-loop control of cellular functions using combinatory drugs guided by a stochastic search algorithm. Proceedings of the National Academy of Sciences of the United States of America 105: 5105-5110.
27. Zinner RG, Barrett BL, Popova E, Damien P, Volgin AY, et al. (2009) Algorithmic guided screening of drug combinations of arbitrary size for activity against cancer cells. Molecular Cancer Therapeutics 8: 521-532.
28. Sun CP, Usui T, Yu F, Al-Shyoukh I, Shamma J, et al. (2009) Integrative systems control approach for reactivating Kaposi's sarcoma-associated herpes-virus (KSHV) with combinatory drugs. Integr Biol (Camb) 1: 123-130.
29. Queipo NV, Haftka RT, Shyy W, Goel T, Vaidyanathan R, et al. (2005) Surrogate-based analysis and optimization. Progress in Aerospace Sciences 41: 1-28.
30. CLSI (2006) Performance Standards for Antimicrobial Susceptibility Testing. Wayne PA: Clinical and Laboratory Standards Institute.
31. Paisley JW, Washington JA (1978) Synergistic Activity of Gentamicin with Trimethoprim or Sulfamethoxazole-Trimethoprim against Escherichia-Coli and Klebsiella-Pneumoniae. Antimicrobial Agents and Chemotherapy 14: 656-658.
32. Zinner SH, Lagast H, Kasry A, Klastersky J (1982) Synergism of trimethoprim combined with aminoglycosides in vitro and in serum of volunteers. Eur J Clin Microbiol 1: 144-148.
33. Mach KE, Du CB, Phull H, Haake DA, Shih MC, et al. (2009) Multiplex Pathogen Identification for Polymicrobial Urinary Tract Infections Using Biosensor Technology: A Prospective Clinical Study. J Urol.
34. Wu J, Balasubramanian S, Kagan D, Manesh KM, Campuzano S, et al. (2010) Motion-based DNA detection using catalytic nanomotors. Nature Communications 1: 36.
35. Mach KE, Mohan R, Baron EJ, Shih MC, Gau V, et al. A Versatile Biosensor Platform for Rapid Antimicrobial Susceptibility Testing Directly from Clinical Samples. Journal of Urology, (in press).
36. Chen CH, Lu Y, Sin ML, Mach KE, Zhang DD, et al. (2010) Antimicrobial susceptibility testing using high surface-to-volume ratio microchannels. Anal Chem 82: 1012-1019.